期刊文献+

急性心肌梗塞患者PCI术前后血清MMP-9与BNP的变化及意义 被引量:8

Changes and clinical significance of matrix metalloproteinases-9 and BNP levels in patients with acute myocardial infarction before and after PCI
下载PDF
导出
摘要 目的:探讨血清基质金属蛋白酶(MMP)-9与B型脑利钠肽(BNP)在急性心肌梗塞(AMI)患者急诊介入治疗前、后含量的变化及其临床意义。方法:选择行急诊经皮冠状动脉介入(PCI)术的AMI患者60例为PCI组,冠状动脉造影正常者30例为正常对照组。采用酶联免疫吸附法(ELISA)检测AMI患者术前及术后第1d血浆MMP-9及BNP的含量,并与对照组检测值进行比较。结果:AMI患者PCI术前MMP-9[(711±169)μg/L∶(216±49)μg/L]及BNP[(329±85)ng/L)∶(29±10)ng/L]水平均较正常对照组明显升高(P均<0.01),且BNP与MMP-9水平呈正相关(r=0.38,P<0.05)。与术前比较,PCI术后血浆BNP明显下降[(329±85)ng/L∶(278±82)ng/L],MMP-9水平明显升高[(711±169)μg/L∶(763±189)μg/L]。结论:MMP-9水平增加可能是心肌缺血再灌注损伤的机制之一,可能与缺血再灌注后的炎症损伤有关。而术前B型脑利钠肽水平升高与炎症损伤有关。 Objective: To explore the changes and clinical significance of matrix metalloproteinases- 9 (MMP -9) and B --type brain natriuretic peptide (BNP) levels in patients with acule myocardial infarction (AMI) before and after PCI. Methods: A total of 60 patients with AM1 who received percutaneous coronary intervention (PC1) were chosen as PCI group, and 30 cases with normal coronary angiography were regard as normal control group. The serum MMP 9 and BNP levels of AMI patients before and 1d after PCI were measured by enzyme-linked immunosorbent assay (ELISA). The results will be compared with those of normal control group. Results: The serum levels of MMP-9 [ (711 ±169)μg/L vs. (216±49)μg/L] and BNP [ (329±85) ng/L) vs. (29±10) ng/L] in AMI patiems before PC1 were significantly higher than those of normal control group (P〈O. 01 all). And the serum BNP level was positive correlated with MMP--9 (r= 0.38, P〈0.05). Compared with preoperative, the plasma BNP level decreased significantly [ (329 ±85) ng/L vs. (278±82) ng/L ], the MMP 9 level increased significantly [ (711±169) lxg/L vs. (763±E189) μg/ L] after PCI. Conclusion: The increase of MMP--9 level may be one of the molecular mechanisms of myocardial ische- mia reperfusion injury, it may be related with inflammatory injuries after myocardial ischemia reperfusion. The increase of serum BNP level before PCI is related with inflammatory injuries.
出处 《心血管康复医学杂志》 CAS 2010年第5期461-463,共3页 Chinese Journal of Cardiovascular Rehabilitation Medicine
基金 黑龙江省卫生厅科研课题(2009-334)
关键词 明胶酶B 利钠肽 心肌梗塞 血管成形术 经腔 经皮冠状动脉 Gelatinase--B Natriuretic peptide, brain Myocardial infarction Angioplasty, transluminal, percutaneous corollary
  • 相关文献

参考文献5

  • 1郭文安,杜心清.基质金属蛋白酶及其抑制物表达平衡失调与心肌梗塞后心室重塑[J].心血管康复医学杂志,2007,16(3):302-305. 被引量:12
  • 2Etoh T, Joffs C, Deschamps AM, et al.Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs[J].Am J Physiol Heart Circ Physiol, 2001, 281(3): 987-994.
  • 3叶榕,江挺,王闽鸿.脑钠肽在慢性心力衰竭中的作用[J].心血管康复医学杂志,2009,18(6):586-588. 被引量:15
  • 4Horio T,Kohno M,Takeda T.Effects of arginine vasopressin angiotensin Ⅱand endothelin-Ⅰ on the release of brain natriuretic peptide in vivo and in vitro[J].Clin Exp Pharmacol Physiol,1992,19(8):575-582.
  • 5Wiezorek SJ,Wu AH,Christensen R,et al.A rapid B-type natriurctie peptide assay accurately diagnoses left ventricular dysfunction and heart failure:a multicenter evaluation[J].Am Heart J,2002,144:834-839.

二级参考文献27

  • 1Hosoda K, Nakao K, Mukoyama M, et al. Expression of brain natriuretic peptide gene in human heart, production in the ventricle [J]. Hypertension, 1997, 17: 1152-1156.
  • 2Mc Donagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left ventricular systolic dysfunction [J]. Lancet, 1998, 35: 9-13.
  • 3Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting [J]. J Am Coll Cardiol, 20010 37: 379-385.
  • 4Troughton RW, Frampton CM, Yandle T, et al. Treatment of heart failure guided by plasma N- BNP concentrations [J].Lancet, 2000, 355 (9210): 1126.
  • 5Yamamoto K, Burnett JC, Jougasaki M, et al. Superiority of BNP as a hormonal maker of ventricular systolic and diastolic dysfunction and ventricular hypertropgy [J]. Hypertension, 1996, 28 (6): 988.
  • 6Maeda K, Tsutarnoto T, Wada A, et al. High level of plasma brain natriuretic peptide and interleukin- 6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure [J]. J AM Coll Cardiol, 2000, 36 (5): 1587.
  • 7Jugdutt BI.Remodeling of the myocardium and potential targets in the collagen degradation and synthesis pathways[J].Curr Drug Targets Cardiovasc Haematol Disord,2003,3 (1):1-30.
  • 8Shah PK.Preservation of cardiac extracellular matrix by passive myocardial restraint:An emerging new therapeutic paradigm in the prevention of adverse remodeling and progressive heart failure[J].Circulation,2005,112:1245-1247.
  • 9Gallagher GL,Jackson CJ,Hunyor SN.Myocardial extracellular matrix remodeling in ischemic heart failure[J].Front Biosci,2007,12:1410-1419.
  • 10Visse R,Nagase H.Matrix Metalloproteinases and tissue inhibitors of metalloproteinases:structure,function,and biochemistry[J].Circulation Research,2003,92 (8):827-839.

共引文献25

同被引文献45

引证文献8

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部